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Summary  The  cardiovascular  system  may  be  involved  as  a  target  organ  of  multifocal  ﬁbroscle-
rosis, which  may  manifest  as  idiopathic  retroperitoneal  ﬁbrosis,  inﬂammatory  aortic  aneurysm,
inﬂammatory  periarteritis,  and  inﬂammatory  pericarditis.  These  pathological  conditions  can
sometimes occur  concomitantly.  Idiopathic  retroperitoneal  ﬁbrosis  and  inﬂammatory  abdom-
inal aortic  aneurysm  are  both  characterized  by  the  presence  of  ﬁbro-inﬂammatory  tissue
around the  abdominal  aorta  expanding  into  the  surrounding  retroperitoneal  structures,  and
together  they  may  be  termed  ‘chronic  periaortitis’.  Cardiovascular  ﬁbrosclerosis  has  become
non-uncommonly  encountered  condition  since  imaging  modalities  have  made  its  diagnosis  more
feasible. In  addition,  recent  studies  have  demonstrated  that  a  certain  fraction,  but  not  all,  of
cardiovascular  ﬁbrosclerosis  may  have  a  link  with  immunoglobulin-G4  (IgG4)-related  sclerosing
disease (IgG4-SD).  IgG4-SD  is  histologically  characterized  by  dense  ﬁbrosclerosis  and  inﬁltration
of lymphocytes  and  IgG4-positive  plasma  cells,  and  these  histopathologic  ﬁndings  seem  to  be
essentially  similar  regardless  of  the  organs  involved.  In  this  mini  review,  we  summarize  what
is known  so  far  about  multifocal  ﬁbrosclerosis  of  the  cardiovascular  system  and  its  association
with IgG4-SD,  and  what  remains  to  be  clariﬁed  in  future  investigations.
© 2011  Japanese  College  of  Cardiology.  Published  by  Elsevier  Ltd.  All  rights  reserved.
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[Introduction
Inﬂammatory  and  immune-mediated  ﬁbrosclerosis  may
involve  various  organs,  including  the  cardiovascular  system
[1,2]. Immunoglobulin  G4  (IgG4),  which  comprises  about
4%  of  total  immunoglobulin  G  (IgG),  is  unable  to  bind  Clq
complement  and  cannot  activate  the  classic  complement
pathway  [3].  Since  Hamano  et  al.  discovered  the  elevation
of  serum  IgG4  levels  and  tissue  inﬁltration  of  IgG4-positive
plasma  cells  in  autoimmune  pancreatitis  in  2001  [4,5], the
relationship  between  IgG4-related  immuno-inﬂammation
and  ﬁbrosclerotic  tissue  degeneration  has  been  gathering
increasing  attention  [6,7], which  is  termed  IgG4-related
sclerosing  disease  (IgG4-SD)  [8]  or  other  synonyms  [9].  IgG4-
SD  is  now  considered  to  encompass  various  organs  including
the  lung  [10], kidney  [11], liver  [12], and  exocrinogical
and  endocrinological  organs  [13—15]. Regardless  of  the
type  of  organs  involved  [16,17],  the  histopathologic  ﬁnd-
ings  of  IgG4-SD  seem  to  be  essentially  similar,  which  are
characterized  by  dense  ﬁbrosclerosis,  intense  inﬂamma-
tory  cell  inﬁltration  with  lymphocytes,  IgG4-positive  plasma
cells,  and  scattered  neutrophils  and  eosinophilic  aggre-
gates  can  also  be  observed  [18]. In  addition,  IgG4-SD
may  appear  as  a  mass-forming  inﬂammatory  pseudotumor
[19,20].
A  growing  body  of  evidence  suggests  that  the  cardiovas-
cular  system  may  become  a  target  of  IgG4-related  multifocal
ﬁbrosclerosis;  it  may  be  manifested  as  idiopathic  retroperi-
toneal  ﬁbrosis,  inﬂammatory  aortic  aneurysm,  coronary
periarteritis  [21—23], and  pericarditis  [24]. In  this  mini
review,  we  discuss  brieﬂy  what  is  known  about  the  car-
diovascular  manifestation  of  multifocal  ﬁbrosclerosis  and
its  relationship  with  IgG4-related  immuno-inﬂammatory
conditions.
Chronic periaortitis
Inﬂammatory  aortic  aneurysm  and  idiopathic  retroperi-
toneal  ﬁbrosis  may  be  grouped  together  under  the
umbrella  of  chronic  periaortitis  according  to  their  com-
mon  histopathological  features  [22,25].  Although  chronic
periaortitis  had  been  considered  to  be  a  relatively  rare
disorder,  its  presence  has  been  increasingly  recognized
t
w
r
bith the  advent  of  non-invasive  imaging  modalities  such  as
omputed  tomography  (CT)  scanning.
linical  pictures  of  chronic  periaortitis
hronic  periaortitis  is  commonly  symptomatic  at  pre-
entation,  with  the  most  frequent  symptom  being  back
nd/or  abdominal  pain  [26,27]. Abnormalities  in  inﬂam-
atory  markers,  such  as  elevated  C-reactive  protein  and
nhanced  erythrocyte  sedimentation  rate,  are  common
aboratory  ﬁndings  [28], and  antinuclear  antigen  may  be
etected  in  about  half  of  all  cases  [26,29]. Macroscop-
cally,  chronic  periaortitis  appears  as  a thick  glistening
etroperitoneal  mass  around  the  abdominal  aorta  or  ileac
rteries  with  a  whitish  surface  [30]. Chronic  periaortitis
ay  be  treated  either  medically  or  surgically.  Cortico-
teroid  and  immunosuppressive  drugs  may  be  effective  in
he  amelioration  of  radiological  ﬁndings  and  in  the  reduc-
ion  of  inﬂammatory  markers  over  a  relatively  short  period
31].
Idiopathic  retroperitoneal  ﬁbrosis,  which  is  also  called
rmond‘s  disease  [32], was  ﬁrst  described  by  Albarran  et  al.
n  1905  [33]. Retroperitoneal  ﬁbrosis  may  be  caused  by
ertain  drugs,  infections,  radiotherapy,  surgery,  and  malig-
ancies  [34]; however,  more  than  two-thirds  of  cases  are
diopathic  in  nature.  Idiopathic  retroperitoneal  ﬁbrosis  has
een  considered  to  be  an  uncommon  condition  with  an
stimated  incidence  of  1.38  per  100,000  inhabitants  [35].
iagnosis  of  this  disease  relies  primarily  on  imaging  studies,
ost  frequently  CT  scanning  [26]; the  disease  is  charac-
erized  by  a  ﬁbroinﬂammatory  soft  tissue  mass  surrounding
he  aorta  and/or  adjacent  tissues.  Biopsy  of  the  retroperi-
oneal  mass  is  currently  less  frequently  performed  due  to
he  potential  risks;  in  some  cases,  however,  the  possibility
f  an  alternative  condition,  such  as  malignancy  or  infection,
hould  be  ruled  out  histopathologically  [36,37].
Inﬂammatory  abdominal  aortic  aneurysm  is  a  patho-
ogical  condition  that  is  estimated  to  account  for  less
han  10%  of  all  cases  of  abdominal  aortic  aneurysm
38,39].  Inﬂammatory  abdominal  aortic  aneurysm  may  be
ermed  the  ‘aneurysmal  form  of  chronic  periaortitis’  and,
hen  accompanied  by  ureteric  blockade,  ‘perianeurysmal
etroperitoneal  ﬁbrosis’  [40], although  these  names  have  not
een  frequently  used  to  date.
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elationship  between  chronic  periaortitis  and
gG4-SD
eild  et  al.  reported  12  patients  with  idiopathic  retroperi-
oneal  ﬁbrosis  which  was  diagnosed  to  be  IgG4-related
istologically  and  immunohistochemically  [18]. In  addition,
en  et  al.  reported  13  cases  of  idiopathic  retroperitoneal
brosis  among  114  patients  with  histopathologically  diag-
osed  IgG4-SD  in  a  cross-sectional  study  [7].  Furthermore,
to  et  al.  reported  a  77-year-old  male  patient  who  presented
ith  malaise  and  intermittent  lower  abdominal  pain  and
as  diagnosed  to  have  inﬂammatory  aortic  aneurysm  which
as  shown  to  be  IgG4-related  immunohistochemically  [41].
hese  ﬁndings  indicate  that  chronic  periaortitis  may,  at  least
n  part,  be  IgG4-related.
Kasashima  et  al.  identiﬁed  23  cases  of  inﬂammatory
neurysm  whose  diagnosis  had  been  made  on  the  basis  of
athological  ﬁndings  from  a  total  of  252  cases  of  surgically
reated  abdominal  aortic  aneurysm,  and  found  that  13  cases
57%)  were  IgG4-related  [42]. No  clear  differences  were
ound  between  IgG4-related  and  non-IgG4-related  inﬂam-
atory  abdominal  aortic  aneurysms  in  terms  of  macroscopic
ndings  in  Kasashima  et  al.’s  series.  In  addition,  Sakata
t  al.  compared  the  clinicopathologic  characteristics  of
ases  of  inﬂammatory  abdominal  aortic  aneurysm  with  age-
nd  sex-adjusted  cases  of  atherosclerotic  abdominal  aortic
neurysm  [43]. They  found  that  inﬁltration  of  IgG4-positive
ell  can  occur  in  atherosclerotic  aortic  aneurysm,  and  that,
onversely,  not  all  cases  of  inﬂammatory  abdominal  aortic
neurysm  are  IgG4-related.  Furthermore,  we  experienced
 patient  with  idiopathic  retroperitoneal  ﬁbrosis  who  had
ormal  serum  IgG4  levels  (Fig.  1A)  [44], and  found  that  the
linical  picture  and  response  to  corticoid  treatment  seemed
o  be  similar  between  IgG4-related  and  non-IgG4-related
diopathic  retroperitoneal  ﬁbrosis  [45]. These  observations
ndicate  that  not  all  the  chronic  periaortitis  may  be  IgG4-
elated  [46].
horacic periaortitis
lthough  the  thoracic  aorta  has  been  considered  relatively
ree  from  the  inﬂammatory  inﬁltration,  several  previous
tudies  reported  inﬂammatory  aortic  aneurysm  or  periaorti-
is  at  the  thoracic  aorta  [47—50]  (Fig.  1B).
linical  pictures  of  thoracic  periaortitis
ahler  et  al.  presented  a  case  with  ﬁbroinﬂammatory
oft  mass  paralleling  the  aortic  arch,  occurrence  of  which
ad  been  preceded  by  the  onset  of  idiopathic  retroperi-
oneal  ﬁbrosis  by  six  years  [51]. In  addition,  Gluhovschi
t  al.  reported  a  45-year  female  who  presented  with  idio-
athic  retroperitoneal  ﬁbrosis  causing  renal  dysfunction
nd  thoracic  periaortitis,  both  of  which  were  ameliorated
y  immunosuppressive  therapy  [52]. It  is  suggested  that
horacic  periaortitis  can  be  a  manifestation  of  systemic
brosclerosis.
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elationship  between  thoracic  periaortitis  and
gG4-SD
ome  previous  studies  have  investigated  an  association
etween  thoracic  aortic  aneurysm/periaortitis  and  IgG4-
elated  immuno-inﬂammation  [16,53,54]. Kasashima  et  al.
erformed  immunohistochemical  analysis  of  the  resected
orta  from  125  patients  of  thoracic  aortic  aneurysm,  and
ound  ﬁve  cases  of  IgG4-SD  [55]; among  them,  one  was
iagnosed  as  inﬂammatory  aneurysm  and  three  were  diag-
osed  as  atherosclerotic  aneurysm.  Thus,  the  prevalence
f  IgG4-SD  among  thoracic  aortic  aneurysm/aortitis  may
e  about  4%  [55]. In  Kasashima  et  al.’s  series,  mean  age
nd  sex-prevalence  were  similar  between  IgG4-related  and
on-IgG4-related  thoracic  aortic  lesions;  on  the  other  hand,
owever,  most  of  the  IgG4-related  thoracic  lesions  were
ocated  at  the  aortic  arch,  particularly  in  the  distal  arch,
ut  only  about  one  third  of  non-IgG4-related  thoracic  lesions
ere  located  at  such  regions.  We  recently  reported  a  case
f  IgG4-related  thoracic  periaortitis  at  the  aortic  arch  [54].
Stone  et  al.  histologically  analyzed  638  resected  aortic
amples  obtained  from  thoracic  aortitis  cases,  and  reported
hat  33  (5.2%)  were  of  a  noninfectious  nature  [16]. In
tone  et  al.’s  study,  one  of  the  cases  of  IgG4-related  tho-
acic  aortitis  developed  IgG4-SD  involving  liver,  pancreas,
nd  submandibular  glands  two  years  after  aortic  resec-
ion,  suggesting  that  IgG4-related  inﬂammatory  thoracic
ortitis  may  also  represent  a vascular  manifestation  of  IgG4-
elated  systemic  ﬁbrosclerosis.  On  the  other  hand,  as  in
he  case  of  abdominal  aortic  aneurysm  [43], inﬁltration  of
gG4-positive  plasma  cells  or  elevated  serum  IgG4  levels
ay  not  be  a  phenomenon  exclusive  to  inﬂammatory  aor-
ic  aneurysm/aortitis  and,  conversely,  inﬂammatory  aortic
neurysm/aortitis  may  not  be  always  associated  with  these
henomena  [56].
nﬂammatory periarteritis — vasculitis of
maller size arteries
evelopment  of  ﬁbrosclerosis  and  inﬁltration  of  inﬂamma-
ory  cell  in  the  perivascular  tissue  may  occur,  albeit  less
requently,  in  smaller-sized  arteries  [57,58], which  may  be
ermed  inﬂammatory  periarteritis  [22].
linical  pictures  of  inﬂammatory  periarteritis
itchinson  et  al.  reported  two  patients  with  ischemic  heart
isease  in  whom  chronic  coronary  periarteritis  was  demon-
trated  histologically  in  conjunction  with  chronic  periaortitis
21].  Maturen  et  al.  have  recently  reported  two  patients
ith  idiopathic  retroperitoneal  ﬁbrosis  who  had  perivascular
ow-attenuation  soft  tissue  surrounding  the  coronary  arter-
es,  illustrated  by  CT,  although  signiﬁcant  luminal  stenosis  of
he  coronary  artery  was  not  noted  at  the  site  of  periarteritis.
59]  (Fig.  2).  These  ﬁndings  suggest  that  coronary  periar-
eritis  may  develop  by  the  same  pathological  mechanisms
s  idiopathic  retroperitoneal  ﬁbrosis.
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Fig.  1  Contrast  enhanced  computed  tomography  of  chronic  periaortitis.  (A)  Retroperitoneal  ﬁbrosis  in  a  reported  case  [44].  (B)
Thoracic periaortitis  in  a  reported  case  [69].
Fig.  2  Contrast  enhanced  computed  tomography  of  a  case  of  idiopathic  retroperitoneal  ﬁbrosis.  (A)  Abnormal  soft  tissue  encasing
normal diameter  left  main  (white  arrowheads)  and  proximal  left  anterior  descending  coronary  arteries  can  be  seen.  (B)  Axial  image
showing the  abnormal  soft  tissue  surrounding  coronary  arteries  (white  arrowheads),  right  paraspinal  mass  (open  arrow),  and  left
pleural effusion  (white  arrows).  Reproduced  from  Maturen  et  al.  [59].
Fig.  3  Proposed  scheme  of  chronic  vasculitis/serositis.  This  clinical  entity  may  have  to  be  reorganized  according  to  the  underlying
immunopathological  background.
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elationship  between  inﬂammatory  periarteritis
nd IgG4-SD
noue  et  al.  demonstrated  17  cases  of  inﬂammatory  periaor-
itis  or  periarteritis  that  had  occurred  in  the  superior
esenteric,  inferior  mesenteric,  and  splenic  arteries  [60],
nd  histologic  examination  of  which,  when  available,
evealed  irregular  ﬁbrosis  in  the  arterial  walls  and  dif-
use  inﬁltration  of  IgG4-positive  cells  within  the  inﬂamed
reas.  In  addition,  Matsumoto  et  al.  presented  a  case  of
gG4-related  abdominal  periaortitis  and  inﬂammatory  coro-
ary  periarteritis,  manifested  as  a  tumorous  mass  around
he  coronary  artery  [17]. Furthermore,  we  have  recently
xperienced  a  patient  with  IgG4-related  periarteritis  of  the
oronary  artery  who  was  admitted  to  our  hospital  owing
o  the  chest  symptoms  [23]. In  this  patient,  serum  IgG4
evels  were  elevated  at  564  mg/dL,  and  a  glittery  white-
ellowish  elastic-hard  periarterial  mass  surrounding  the  left
ircumﬂex  artery  could  be  seen  after  the  incision  of  the  peri-
ardium.  Whether  IgG4-related  coronary  periarteritis  plays  a
ole  in  the  development  of  coronary  artery  stenosis  remains
o  be  investigated,  however,  we  may  have  to  be,  at  least,
ware  that  coronary  periarteritis  may  increasingly  be  diag-
osed  in  the  era  of  multi-detector  coronary-CT  angiography.
nﬂammatory pericarditis and IgG4-SD
everal  reports  have  demonstrated  inﬂammatory  pericar-
ial  ﬁbrosis  that  occurred  as  a  manifestation  of  systemic
ultifocal  ﬁbrosclerosis  [2,24]. Sugimoto  et  al.  reported
 68-year-old  man  who  showed  constrictive  pericarditis  as
he  initial  manifestation,  and  staining  of  the  excised  peri-
ardium  with  anti-IgG4  antibody  revealed  the  inﬁltration
f  IgG4-positive  plasma  cell  [61]. This  patient  developed
leural  effusion  and  progressive  pleural  ﬁbrosis  six  months
fter  post-pericardiostomy.  We  have  recently  reported  an
3-year-old  man  with  pericardial  ﬁbrosis  who  died  from
ardio-respiratory  failure  due  to  massive  pericardial  effu-
ion,  and  autopsy  showed  the  inﬁltration  of  IgG4-positive
lasma  cells  in  the  pericardium,  as  well  as  in  the  visceral
nd  parietal  pleura,  pancreas,  and  retroperitoneal  ﬁbrous
issues  [45]. This  patient  had  a  past  history  of  autoimmune
ancreatitis.  These  observations  were  consistent  with  the
otion  that  inﬂammatory  pericarditis  may  also  develop  as  a
eature  of  IgG4-related  multifocal  ﬁbrosclerosis.
ibroinﬂammatory disorders of myocardium
hether  IgG4-related  immuno-inﬂammation  may  underlie
yocardial  ﬁbrosclerosis  that  would  lead  to  cardiac  fail-
re  seems  to  have  been  least  extensively  studied  [62,63].
ardiac  sarcoidosis  may  be  one  of  the  disorders  associated
ith  the  inﬁltration  of  lymphocytic  cells  and  development
f  ﬁbrosis  in  the  heart  [64]. We  investigated  the  relation-
hip  between  IgG4-SD  and  cardiac  sarcoidosis;  however,  we
ould  not  ﬁnd  a  meaningful  relationship  between  these  con-
itions  [65]. Whether  IgG4-related  immuno-inﬂammation
ould  underlie  the  pathogenesis  of  other  myocardial  disor-
ers  causing  ﬁbrosis  and  cardiac  failure  should  be  assessed
n  further  studies.
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urdles to overcome for further investigations
s  discussed  above,  IgG4-related  autoimmunity  may,
lthough  not  always,  underlie  multifocal  ﬁbrosclerosis
n  the  cardiovascular  system.  Toward  achieving  optimal
herapeutic  strategies  and  better  understanding  of  the
athophysiology  of  IgG4-related  ﬁbrosclerosis  in  the  cardio-
ascular  system,  there  is  an  increasing  need  for  research  in
his  ﬁeld;  however,  there  are  several  hurdles  to  overcome
efore  advances  can  be  made.
First,  the  deﬁnition,  as  well  as  the  nomenclature,  of  the
isorder.  Inﬂammatory  aortic  aneurysm  is  said  to  be  present
hen  periaortic  ﬁbrosis  coexists  with  dilatation  of  the  aorta;
owever,  the  cut-off  value  of  aortic  diameter  that  dis-
riminates  between  idiopathic  retroperitoneal  ﬁbrosis  and
nﬂammatory  abdominal  aortic  aneurysm  does  not  seem  to
e  clear  [34], or  may  sometimes  be  impractical.  Likewise,
etroperitoneal  ﬁbrosis  may  be  subclassiﬁed  as  IgG4-related
nd  non-IgG4-related  forms;  alternatively,  however,  it  may
lso  be  subclassiﬁed  as  idiopathic  and  secondary  forms.
urthermore,  because  IgG4-related  ﬁbrosclerosis  can  also
ccur  in  small-size  vessels,  pericardium,  and  possibly
leura,  it  might  more  suitably  be  termed  ‘IgG4-related
peri)vasculitis/serositis’  (Fig.  3).
Second,  differential  diagnosis.  In  infected,  or  mycotic,
ortic  aneurysm,  the  bacterial  culture  may  be  negative  in
alf  of  all  cases  [66]  and  serum  IgG4  levels  might  be  elevated
67].  Considering  that  about  half  of  all  cases  of  inﬂammatory
ortic  aneurysm  may  be  IgG4-related  [29], these  situations
ay  make  differential  diagnosis  between  inﬂammatory  and
nfected  aneurysm  difﬁcult.  In  addition,  it  should  also  be
oted  that  diagnosis  of  IgG4-related  or  non-IgG4-related
ultifocal  ﬁbrosclerosis  should  not  be  made  solely  depend-
ng  on  the  responsiveness  to  medical  therapy,  because  some
ypes  of  malignancy  that  might  underlie  or  be  misdiagnosed
s  ﬁbrosclerotic  disorders  may  also  respond  to  corticoste-
oid  therapy  [68]. In  patients  with  multiorgan  ﬁbrosis,  we
hould  not  overlook  the  possibility  of  malignant  disease.
Third,  IgG4  positivity.  Clinical  pictures  and  therapeu-
ic  responsiveness  of  non-IgG4-related  ﬁbrosclerosis  may  be
imilar,  sometimes  almost  identical,  to  IgG4-SD.  It  is  pos-
ible  that  IgG4-positive  cell  inﬁltration  may  be  a transient
henomenon  during  the  development  of  ﬁbrosclerotic  tis-
ue  degeneration  and  that  IgG4  may  not  play  a  central,  but
ather  a  bystander,  role  in  the  lesion  formation.
onclusion
he  cardiovascular  system  may  be  one  of  the  target  organs
f  IgG4-related,  and  non-IgG4-related,  systemic  multifocal
brosclerosis.  Cardiologists  should  be  aware  of  this  clinico-
athological  condition,  not  only  because  it  can  be  potently
anaged  by  corticosteroid  and/or  immunosuppressive  ther-
pies,  but  also  because  it  can  take  a  rapid  and  fatal  clinical
ourse  [45]. In  addition,  caution  should  be  applied  because
ardiovascular  ﬁbrosclerosis  may  be  accompanied  by  or  mis-
iagnosed  from  other  co-morbidities  such  as  infection  and
alignancy.  Further  research  is  warranted  in  the  ﬁeld  of
gG4-related  cardiovascular  ﬁbrosclerosis.
he  c
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